AV
GILD icon

ASR Vermogensbeheer’s Gilead Sciences GILD Stock Holding History

ASR Vermogensbeheer’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22M Buy
174,035
+57,106
+49% +$7.52M 0.23% 96
2026
Q1 		$16.3M Buy
116,929
+3,075
+3% +$431K 0.19% 113
2025
Q4 		$14M Buy
113,854
+6,627
+6% +$805K 0.16% 129
2025
Q3 		$11.9M Sell
107,227
-363
-0.3% -$41.3K 0.14% 134
2025
Q2 		$11.9M Buy
107,590
+3,277
+3% +$349K 0.15% 123
2025
Q1 		$11.7M Buy
+104,313
New +$10.8M 0.17% 122

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ASR Vermogensbeheer's GILD Position: Q2 2026 in Review

ASR Vermogensbeheer increased its Gilead Sciences (GILD) stake by 49% in Q2 2026, buying an estimated $7.52M and bringing the position to 174,035 shares worth $22M. The position accounts for 0.23% of the portfolio, ranked #96.

ASR Vermogensbeheer first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • ASR Vermogensbeheer held 174,035 shares of Gilead Sciences worth $22M as of Q2 2026.
  • ASR Vermogensbeheer bought 57,106 Gilead Sciences shares in Q2 2026, an estimated $7.52M.
  • Gilead Sciences made up 0.23% of ASR Vermogensbeheer's portfolio in Q2 2026, its #96 holding.
  • ASR Vermogensbeheer first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.